Search
Mereo BioPharma Group PLC
MREOAdd to Watchlist
0.288USD
-0.003-1.10%
Close 07-24 16:00（ET）Quotes delayed by 15 min
229.69MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Rubric Capital Management LP
9.59%
683 Capital Management LLC
9.41%
EcoR1 Capital, LLC
9.33%
Schonfeld Strategic Advisors LLC
3.82%
Tejara Capital Ltd.
1.28%
Other
66.57%
Shareholders
Shareholders
Proportion
Rubric Capital Management LP
9.59%
683 Capital Management LLC
9.41%
EcoR1 Capital, LLC
9.33%
Schonfeld Strategic Advisors LLC
3.82%
Tejara Capital Ltd.
1.28%
Other
66.57%
Shareholder Types
Shareholders
Proportion
Hedge Fund
25.60%
Investment Advisor/Hedge Fund
9.66%
Investment Advisor
5.66%
Research Firm
1.73%
Venture Capital
1.16%
Individual Investor
0.86%
Other
55.33%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
185
69.97M
43.84%
-68.14M
2025Q4
175
114.02M
71.65%
+209.62K
2025Q3
170
111.71M
70.22%
-5.91M
2025Q2
167
124.56M
78.34%
-3.58M
2025Q1
176
112.84M
70.99%
-23.15M
2024Q4
174
116.69M
75.21%
-16.90M
2024Q3
167
107.29M
69.42%
-17.56M
2024Q2
164
101.82M
66.22%
-5.20M
2024Q1
162
84.96M
60.56%
-41.79M
2023Q4
143
78.69M
56.11%
-37.03M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Rubric Capital Management LP
15.31M
9.59%
--
--
Dec 31, 2025
683 Capital Management LLC
15.03M
9.41%
+10.15M
+208.21%
Dec 31, 2025
EcoR1 Capital, LLC
14.90M
9.33%
+7.04M
+89.65%
Jan 02, 2026
Schonfeld Strategic Advisors LLC
6.09M
3.82%
+4.36M
+251.49%
Dec 31, 2025
Tejara Capital Ltd.
2.16M
1.35%
+252.84K
+13.26%
Dec 31, 2025
Logos Global Management LP
1.85M
1.16%
+1.35M
+270.00%
Dec 31, 2025
UBS Asset Management (Switzerland)
1.76M
1.1%
-143.11K
-7.51%
Dec 31, 2025
Balyasny Asset Management LP
1.28M
0.8%
+1.28M
--
Dec 31, 2025
Morgan Stanley & Co. LLC
1.27M
0.8%
-470.07K
-27.00%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Genomics Immunology and Healthcare ETF
0.58%
Virtus LifeSci Biotech Clinical Trials ETF
0.46%
SPDR S&P International Small Cap ETF
0.03%
ActivePassive International Equity ETF
0.01%
Tema Heart & Health ETF
0%
Tema Oncology ETF
0%
Formidable ETF
0%
iShares Genomics Immunology and Healthcare ETF
Proportion0.58%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.46%
SPDR S&P International Small Cap ETF
Proportion0.03%
ActivePassive International Equity ETF
Proportion0.01%
Tema Heart & Health ETF
Proportion0%
Tema Oncology ETF
Proportion0%
Formidable ETF
Proportion0%